A novel optically pure pyridazinone derivative was synthesized and identifi
ed as a nonprostanoid PGI(2) agonist. It inhibited ADP-induced aggregation
of human platelets with an IC50 value of 0.081 muM and has high oral bioava
ilability (56%) with a long half-life (4.3 h) in rats. (C) 2000 Elsevier Sc
ience Ltd. All rights reserved.